Payments to Acquire Property, Plant, and Equipment of ARROWHEAD PHARMACEUTICALS, INC. from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Dec 2025 was $2,148,000, a 71% decline year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $22,666,000, a 84% decline from 2024.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $141,469,000, a 20% decline from 2023.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $176,737,000, a 235% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,148,000 -$5,368,000 -71% 01 Oct 2025 31 Dec 2025 10-Q 05 Feb 2026 2026 Q1
Q4 2024 $7,516,000 -$61,140,000 -89% 01 Oct 2024 31 Dec 2024 10-Q 05 Feb 2026 2026 Q1
Q4 2023 $68,656,000 +$29,745,000 +76% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025 2025 Q1
Q4 2022 $38,911,000 +$33,133,000 +573% 01 Oct 2022 31 Dec 2022 10-Q 06 Feb 2024 2024 Q1
Q4 2021 $5,778,000 +$1,507,000 +35% 01 Oct 2021 31 Dec 2021 10-Q 06 Feb 2023 2023 Q1
Q4 2020 $4,271,000 -$49,000 -1.1% 01 Oct 2020 31 Dec 2020 10-Q 02 Feb 2022 2022 Q1
Q4 2019 $4,320,000 +$3,582,513 +486% 01 Oct 2019 31 Dec 2019 10-Q 04 Feb 2021 2021 Q1
Q4 2018 $737,487 +$602,073 +445% 01 Oct 2018 31 Dec 2018 10-Q 05 Feb 2020 2020 Q1
Q4 2017 $135,414 -$5,161,239 -97% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q1
Q4 2016 $5,296,653 +$4,890,041 +1203% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018 2018 Q1
Q4 2015 $406,612 -$148,333 -27% 01 Oct 2015 31 Dec 2015 10-Q 06 Feb 2017 2017 Q1
Q4 2014 $554,945 +$438,730 +378% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q1
Q4 2013 $116,215 +$106,776 +1131% 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q1
Q4 2012 $9,439 -$59,985 -86% 01 Oct 2012 31 Dec 2012 10-Q 04 Feb 2014 2014 Q1
Q4 2011 $69,424 01 Oct 2011 31 Dec 2011 10-Q 13 Feb 2013 2013 Q1

ARROWHEAD PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $22,666,000 -$118,803,000 -84% 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025 2025 FY
2024 $141,469,000 -$35,268,000 -20% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025 2025 FY
2023 $176,737,000 +$123,960,000 +235% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025 2025 FY
2022 $52,777,000 +$29,210,000 +124% 01 Oct 2021 30 Sep 2022 10-K 26 Nov 2024 2024 FY
2021 $23,567,000 +$11,615,000 +97% 01 Oct 2020 30 Sep 2021 10-K 29 Nov 2023 2023 FY
2020 $11,952,000 -$49,000 -0.41% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022 2022 FY
2019 $12,001,000 +$10,579,748 +744% 01 Oct 2018 30 Sep 2019 10-K 22 Nov 2021 2021 FY
2018 $1,421,252 -$6,496,946 -82% 01 Oct 2017 30 Sep 2018 10-K 23 Nov 2020 2020 FY
2017 $7,918,198 +$4,057,961 +105% 01 Oct 2016 30 Sep 2017 10-K 25 Nov 2019 2019 FY
2016 $3,860,237 +$1,889,625 +96% 01 Oct 2015 30 Sep 2016 10-K 11 Dec 2018 2018 FY
2015 $1,970,612 +$253,250 +15% 01 Oct 2014 30 Sep 2015 10-K 12 Dec 2017 2017 FY
2014 $1,717,362 +$1,420,482 +478% 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016 2016 FY
2013 $296,880 -$182,830 -38% 01 Oct 2012 30 Sep 2013 10-K 14 Dec 2015 2015 FY
2012 $479,710 +$470,036 +4859% 01 Oct 2011 30 Sep 2012 10-K 25 Nov 2014 2014 FY
2011 $9,674 01 Oct 2010 30 Sep 2011 10-K 28 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.